✦ LIBER ✦

Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription

✍ Scribed by Dilworth, F Jeffrey; Chambon, Pierre

Book ID: 110064619
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 218 KB
Volume: 20
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1204329

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The interaction between thymine DNA glyc

The interaction between thymine DNA glycosylase and nuclear receptor coactivator 3 is required for the transcriptional activation of nuclear hormone receptors

✍ Shirley Chiang; Tanya Burch; Gary Van Domselaar; Kevin Dick; Alina Radziwon; Cra 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 568 KB

Surface-active metal-coordinated oligope

Surface-active metal-coordinated oligoperoxidic radical initiators. I. The interrelation between the microstructure of ditertiary oligoperoxides and their ability to form stable metal complexes

✍ A. Zaichenko; N. Mitina; M. Kovbuz; I. Artym; S. Voronov 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Carbon-chain heterofunctional oligoperoxides (HFOs) with ditertiary peroxidic, carboxy, or hydroxy groups formed stable coordinated complexes through their interaction with transition-metal salts in organic solutions. The oligomeric metal complexes (OMCs) were separated from the reaction mixture and

Resistance to 1,25D-induced differentiat

Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor

✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o